1. Guidance for industry: development and use of risk minimization action plans,2005
2. Guidance for industry: good pharmacovigilance practice and pharmacoepidemiologic assessment,2005
3. Cutaneous drug reactions;Svensson;Pharmacol Rev,2001
4. Epidemiology of cutaneous drug-induced reactions;Naldi;G Ital Dermatol Venereol,2014
5. Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982;Bigby;JAMA,1986